Holdings

杭州中美华东制药有限公司

As of Aug 28, 2025, 杭州中美华东制药有限公司 reported 2 positions. Largest: Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. Class H and Qyuns Therapeutics Co., Ltd. Class H. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. Class H12.6Mfirst reportNov 28, 2024
Qyuns Therapeutics Co., Ltd. Class H35.9Mfirst reportAug 28, 2025